Request Your Free Playbook Now:

"How Employers Can Deliver Obesity-Related Care"

This playbook explores what you to know about GLP-1s, the next generation of weight loss treatment.

As employers, not paying attention to obesity can create costly problems down the road for you and your affected employees. 

For one, obesity causes a higher risk for other, expensive and difficult-to-manage conditions such as heart disease, stroke, type 2 diabetes and certain types of cancer.   

The CDC also notes diabetes alone costs employers $90 billion annually, including increased absenteeism ($3.3B) and reduced productivity ($26.9B).  

Unfortunately, while new-age treatments like GLP-1s are available to help alleviate the risks, they are expensive without the right partner to help manage. It’s up to employers to take steps to provide employees with the appropriate (and cost-effective) options or it can cost your company.

In this playbook, we explore:

• GLP-1s and why they are trending
• GLP-1 misconceptions—with facts
• As employers, why it’s time to view weight loss differently when it comes to employee benefit plans

Offered Free by: HR Dive's studioID and Calibrate
See All Resources from: HR Dive's studioID and Calibrate